Prognosis
Australia Backs AstraZeneca Vaccine as Blood Clots Probed
Vials of the AstraZeneca Plc and the University of Oxford Covid-19 vaccine.
Photographer: Anthony Devlin/BloombergThis article is for subscribers only.
For a fresh perspective on the stories that matter for Australian business and politics, sign up for our weekly newsletter.
Australia won’t pause the rollout of AstraZeneca Plc’s Covid-19 vaccine, even as some European countries temporarily suspend use of the shots while possible blood clots are investigated.